MIRA
INFORM REPORT
|
Report Date : |
07.01.2012 |
IDENTIFICATION DETAILS
|
Name : |
NCPC ORCHID PHARMA CO., LTD. |
|
|
|
|
Registered Office : |
No. 18 Yangzi Road, Liangcun Economic & Technical
Development Zone, Shijiazhuang, Hebei Province 052165 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
02.09.2002 |
|
|
|
|
Com. Reg. No.: |
130000400001143 |
|
|
|
|
Legal Form : |
Chinese-Foreign Equity Joint Venture
Enterprise |
|
|
|
|
Line of Business : |
Manufacturing, selling, R&D and developing Cephalosporin API. |
|
|
|
|
No. of Employees : |
240 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 1,200,000 |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
NCPC ORCHID PHARMA CO., LTD.
NO. 18 YANGZI ROAD, LIANGCUN ECONOMIC & TECHNICAL
DEVELOPMENT ZONE, SHIJIAZHUANG, HEBEI PROVINCE 052165 PR CHINA
TEL: 86 (0) 311-86695764/86051384/86691590
FAX: 86 (0) 311-86051349
EXECUTIVE SUMMARY
Date of Registration : september 2, 2002
REGISTRATION NO. : 130000400001143
LEGAL FORM : Chinese-foreign equity joint venture
enterprise
REGISTERED CAPITAL : usd 10,000,000
staff : 240
BUSINESS CATEGORY : manufacturing
Revenue :
CNY 365,209,000 (AS OF DEC. 31,
2010)
EQUITIES :
CNY 152,913,000 (AS OF DEC. 31, 2010)
WEBSITE : N/A
E-MAIL :
N/A
PAYMENT :
AVERAGE
Recommended Credit Limit: UP TO USD 1,200,000
MARKET CONDITION : COMPETITIVE
FINANCIAL CONDITION : FAIRly
good
OPERATIONAL TREND : STEADY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.30 = USD 1
Adopted abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
LEGAL STATUS & HISTORY
SC was established
as a Chinese-foreign equity joint venture enterprise of PRC with State
Administration of Industry & Commerce (SAIC) under registration No.:
130000400001143 on September 2, 2002.
SC’s Organization Code Certificate No.:
74152780-3
SC’s Tax No.: 130182741527803
SC’s Customs registration No.: 1301330059
SC’s registered capital: usd 10,000,000
SC’s paid-in capital: usd 10,000,000
Registration Change Record:
No significant changes of SC have been noted
in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
North China Pharmaceutical Company Ltd. |
50 |
|
India Orchid Chemical Pharmaceutical Co.,
Ltd. |
50 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman, and
General Manager |
Wei Qingjie |
RECENT DEVELOPMENT
No recent development was found during our checks at present.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
North China Pharmaceutical Company Ltd. 50
India Orchid Chemicals & Pharmaceuticals
Ltd. 50
North China Pharmaceutical Company Ltd.
===================================
Date of Registration: August 25, 1992
Registration No.: 130000000008365
Legal Form: Shares Limited
Company
Registered Capital: CNY 1,028,580,000
India Orchid Chemicals & Pharmaceuticals Ltd.
======================================
#313, Valluvar Kottam High Road
Nungambakkam
Chennai - 600 034
Tamil Nadu, India
Phone: +91 - 44 - 2821 1000 / 2823 0000
Fax: +91 - 44 - 2821 1002
Web: www.orchidpharma.com
E-mail: corporate@orchidpharma.com
MANAGEMENT
Wei Qingjie ,
Legal Representative, Chairman and General Manager
----------------------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Age: 43
Ø
Qualification:
University
Ø
Working
experience (s):
Before, worked in SC as deputy general manager
At present, working in SC as legal representative,
chairman and general manager
Also working in NCPC Hebei Huamin Pharmaceutical Co.,
Ltd. as chairman and general manager, working in North China Pharmaceutical
Company Ltd. as deputy general manager
BUSINESS OPERATION
SC’s registered business scope includes manufacturing,
selling, R&D and developing Cephalosporin API.
SC is mainly
engaged in manufacturing and selling Cephalosporin API.
SC’s products mainly
include: Cephalosporin API.
SC sources its materials 40% from domestic
market, 60% from overseas market. SC sells 100% of its products in domestic
market.
The buying terms
of SC include T/T, L/C and Credit of 30-60 days. The payment terms of SC include
T/T and Credit of 30-60 days.
Staff & Office:
--------------------------
SC is known
to have approx. 240 staff at
present.
SC owns an area as
its operating office & factory of approx. 14,663 sq. meters at the heading
address.
RELATED COMPANY
SC
is not known to have any subsidiary at present.
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
The bank
information of SC is not filed in SAIC.
FINANCIALS
Balance Sheet
|
Unit: CNY’000 |
As
of Dec. 31, 2009 |
As
of Dec. 31, 2010 |
|
35,776 |
24,813 |
|
|
Notes receivable |
19,537 |
35,938 |
|
Accounts
receivable |
45,841 |
62,098 |
|
Advances to
suppliers |
3,791 |
3,744 |
|
Other receivable |
407 |
6,073 |
|
Inventory |
63,620 |
64,486 |
|
Non-current
assets within one year |
0 |
0 |
|
Other current
assets |
0 |
986 |
|
|
------------------ |
------------------ |
|
Current assets |
168,972 |
198,138 |
|
Fixed assets |
82,345 |
80,585 |
|
Construction in
progress |
1,493 |
3,556 |
|
Intangible
assets |
10,687 |
8,899 |
|
Long-term
prepaid expenses |
0 |
0 |
|
Deferred income
tax assets |
0 |
0 |
|
Other
non-current assets |
0 |
0 |
|
|
------------------ |
------------------ |
|
Total assets |
263,497 |
291,178 |
|
|
============= |
============= |
|
Short-term loans |
30,000 |
27,000 |
|
Notes payable |
0 |
0 |
|
Accounts payable |
78,963 |
91,322 |
|
Wages payable |
2,682 |